Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials.
about
Comparison of stem cell therapies for acute kidney injuryMesenchymal stem/stromal cells as a delivery platform in cell and gene therapiesHuman adipose stromal cell therapy improves survival and reduces renal inflammation and capillary rarefaction in acute kidney injury.Cellular therapies in trauma and critical care medicine: Looking towards the futureEndothelial Colony Forming Cells (ECFCs) in murine AKI - implications for future cell-based therapies.Endothelial colony-forming cells ameliorate endothelial dysfunction via secreted factors following ischemia-reperfusion injury.Challenges and opportunities for stem cell therapy in patients with chronic kidney diseaseCellular Therapies in Trauma and Critical Care Medicine: Forging New FrontiersStem cells and their role in renal ischaemia reperfusion injury.Concise review: mesenchymal stem cell treatment for ischemic kidney diseaseDesigning drugs that combat kidney damage.The exciting "bench to bedside" journey of cell therapies for acute kidney injury and renal transplantation.Healing the damaged mesangium in nodular glomerulosclerosis using mesenchymal stem cells (MSCs): Expectations and challenges.Mesenchymal stromal cells with enhanced therapeutic properties.Nuclear factor erythroid-2 related factor 2 overexpressed mesenchymal stem cells transplantation, improves renal function, decreases injuries markers and increases repair markers in glycerol-induced Acute kidney injury rats.Selected renal cells modulate disease progression in rodent models of chronic kidney disease via NF-κB and TGF-β1 pathways.Mesenchymal stem cell-derived extracellular vesicles for kidney repair: current status and looming challenges.Umbilical cord mesenchymal stem cell transplantation ameliorates burn-induced acute kidney injury in rats.Intra-arterial catheter system to repeatedly deliver mesenchymal stem cells in a rat renal failure model.Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production.Acute Kidney Injury as a Condition of Renal Senescence.The endothelial-to-mesenchymal transition and endothelial cilia in EPC-mediated postischemic kidney protection.Novel preconditioning strategies for enhancing the migratory ability of mesenchymal stem cells in acute kidney injuryeffects of allogeneic mesenchymal stem cells in a rat model of acute ischemic kidney injury
P2860
Q26747592-8155A81D-0B1B-4C41-B0BB-8DCB7998037BQ26799107-D32BA949-8D7E-4558-B817-AE806886ECB9Q33844666-1DE9FE9C-CCE4-4461-85E8-1CC0BAE64DBEQ33898175-22F1F7C2-7AAA-4F0A-91DA-68905A2E6BB9Q36271958-B7FA61BE-60AA-4DF0-B5BA-C5660BAD885EQ36287886-437A2C0E-8C3D-4DAD-8B11-D80064E8C9B3Q36711673-BDD97F34-4F9D-4413-8E4E-25229908FD9CQ36852274-0DBC7B0F-BB35-4E44-8050-994A51AAE5A4Q38072245-AFDD8AB4-8769-409D-A08A-DD19C7A0791CQ38114399-CDB60E22-8122-4A65-AE7E-5B61243A2668Q38404587-8B6093CF-742B-49DF-A077-827CCA197B59Q38558079-0781DAF7-6674-43B3-80A9-917208C799A3Q38794341-70CE7E83-A0DD-442D-85D3-E5BA4490154FQ39045625-A20B1CD3-B75C-42A2-A7F5-3D95D65564A2Q40258305-B7297E99-D5A0-41A6-8347-7656F34A76AAQ45880706-715E3E78-DA64-4709-B345-1D67EAFF7A2CQ47136990-8EE1C2A5-784D-4DC4-AFEA-81C61B6B8588Q47978052-D993A96E-21C0-4112-A782-ABE25C2F4A3BQ48653733-D90E1551-5DE5-417A-AA9E-955477604D3EQ49177880-AC122CC2-6AF8-4630-9C19-F675D63E0269Q52559612-393A0A4A-A744-489C-B4BF-8950847DBC16Q53201629-05C4C58A-0489-473D-BFB4-915BBEFE50EAQ58713633-CC474CA1-6B4D-4D74-B6B2-D10EEE9715F5Q58805029-CBFF7330-0667-4701-A938-71FEC52EA490
P2860
Protective actions of administered mesenchymal stem cells in acute kidney injury: relevance to clinical trials.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Protective actions of administ ...... relevance to clinical trials.
@en
Protective actions of administ ...... relevance to clinical trials.
@nl
type
label
Protective actions of administ ...... relevance to clinical trials.
@en
Protective actions of administ ...... relevance to clinical trials.
@nl
prefLabel
Protective actions of administ ...... relevance to clinical trials.
@en
Protective actions of administ ...... relevance to clinical trials.
@nl
P2860
P356
P1476
Protective actions of administ ...... relevance to clinical trials.
@en
P2093
Christof Westenfelder
Florian E Togel
P2860
P2888
P304
P356
10.1038/KISUP.2011.24
P577
2011-09-01T00:00:00Z
P5875
P6179
1050563955